NORMAL SITUATION

HEX Lab

Financial year 2021 · closed on 31/12/2021
Net result
203,9 k €
+192.0% YoY
Gross margin
386,6 k €
+342.6% YoY
Equity
94 k €
+166.0% YoY
Workforce
2,4 ETP
+9.1% YoY

Company — Normal situation.

What does HEX Lab do?

HEX Lab is a company registered in Belgium. It employs on average 2,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0719.935.879
Legal form
Private company with limited liability
Contributed capital
18 600,00 €
Latest accounts
31/12/2021
Average workforce
2,4 ETP
Joint committees (1)
  • 207
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20212020
Income statement
Gross margin386,6 k €-159,4 k €
EBITDA299,2 k €-207,9 k €
Operating result199,3 k €-240,5 k €
Net result203,9 k €-221,7 k €
Balance sheet
Equity94 k €-142,5 k €
Total assets851 k €602,6 k €
Cash118 k €45,5 k €
Debts757 k €745,1 k €
Other
Workforce2,4 ETP2,2 ETP
Governance

Board of directors

Seen on filing of 31/12/2021 · 3 active · 3 ended

Active mandates

PHARMA BIO CONSULT

Director · since 06 février 2019 · 0719.347.149

Represented by Franck POLYN

Active
TECHNICAL CONSULTING CONCEPT

Director · since 06 février 2019 · 0598.819.404

Represented by David DENEUVILLE

Active
TRAINING & CONSULTING TW

Director · since 06 février 2019 · 0598.819.305

Represented by Tony WATTRELOT

Active

Ended mandates

PHARMA BIO CONSULT

Director · since 06 février 2019 · 0719.347.149

Represented by POLYN Franck

Ended
TECHNICAL CONSULTING CONCEPT

Director · since 06 février 2019 · 0598.819.404

Represented by DENEUVILLE David

Ended
TRAINING & CONSULTING TW

Director · since 06 février 2019 · 0598.819.305

Represented by WATTRELOT Tony

Ended
Annual accounts

Full financial information

202120202019
Type of accountAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202101/01/202001/01/2019
Closing of the financial year31/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months
Filing date29/06/202222/07/202102/07/2020
General meeting27/05/202228/05/202129/05/2020
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202127/05/202229/06/2022FrenchPDF
Abridged model31/12/202028/05/202122/07/2021FrenchPDF
Abridged model31/12/201929/05/202002/07/2020FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 3 active · 3 ended

Active mandates

PHARMA BIO CONSULT

Director · since 06 février 2019 · 0719.347.149

Represented by Franck POLYN

Active
TECHNICAL CONSULTING CONCEPT

Director · since 06 février 2019 · 0598.819.404

Represented by David DENEUVILLE

Active
TRAINING & CONSULTING TW

Director · since 06 février 2019 · 0598.819.305

Represented by Tony WATTRELOT

Active

Ended mandates

PHARMA BIO CONSULT

Director · since 06 février 2019 · 0719.347.149

Represented by POLYN Franck

Ended
TECHNICAL CONSULTING CONCEPT

Director · since 06 février 2019 · 0598.819.404

Represented by DENEUVILLE David

Ended
TRAINING & CONSULTING TW

Director · since 06 février 2019 · 0598.819.305

Represented by WATTRELOT Tony

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2021
    Annual accounts 2021203,9 k €
  2. 2020
    Annual accounts 2020-221,7 k €